Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5925_Библиотеки_им_академика_М_И_Перельмана.pdf
40 1 Comprehensive Insights into Pharmaceutical Analysis
1.8.41 Good Manufacturing Practices
A set of regulations and guidelines governing the manufacturing and quality control
of pharmaceutical products.
1.8.42 Regulatory Compliance
Adherence to laws and regulations governing the pharmaceutical industry to ensure
product safety and quality.
1.8.43 Batch Release
The process of approving and releasing a batch of pharmaceutical products for
distribution.
1.8.44 Formulation
The specific combination of active ingredients and excipients used to create a
pharmaceutical product.
1.8.45 Dosage Form
The physical form of a pharmaceutical product, such as tablets, capsules, solutions,
or creams.
1.8.46 Counterfeit Drugs
Fake or substandard pharmaceutical products that can be dangerous to public health.
1.8.47 Range of method
The range of a method in pharmaceutical analysis refers to the concentration or
amount range over which an analytical method can provide accurate and precise
results for a specific analyte. It defines the scope or working range of the method and
is a crucial parameter in analytical chemistry, particularly in pharmaceutical quality
control and research.
1.9 Calibration of Analytical Method for Pharmaceutical Analysis 41
1.9 Calibration of Analytical Method for Pharmaceutical
Analysis
Calibration of analytical methods is a critical step in pharmaceutical analysis to
ensure that the method provides accurate and reliable results. The calibration process
involves establishing a relationship between the instrument’s response and the
concentration or quantity of the analyte (the substance being measured). This
relationship allows for the quantification of the analyte in unknown samples based
on the instrument’s response. Here are the key steps and considerations in the
calibration of analytical methods for pharmaceutical analysis:
1.9.1 Select Suitable Standards
Choose appropriate standard solutions for the analyte. These standards should cover
a range of concentrations, including a blank (no analyte) and a range of
concentrations that encompass the expected concentration levels in the samples.
1.9.2 Instrument Calibration
Calibrate the analytical instrument (e.g., spectrophotometer, chromatograph) using
the standard solutions. This involves setting the instrument to a specific wavelength
or measurement condition and recording the instrument’s response (e.g., absorbance,
peak area) for each standard.
1.9.3 Generate Calibration Curve
Plot the instrument’s response (e.g., signal) against the known concentration of the
analyte. A calibration curve is typically a linear relationship, and it can be expressed
by a mathematical equation (e.g., a linear regression equation).
1.9.4 Evaluate Linearity
Assess the linearity of the calibration curve by examining the correlation coefficient
(R-squared) or other statistical measures. A high R-squared value indicates a strong
linear relationship.
42 1 Comprehensive Insights into Pharmaceutical Analysis
1.9.5 Calculate Regression Equation
Determine the regression equation for the calibration curve. This equation relates the
instrument’s response to the concentration of the analyte, allowing you to predict the
concentration of analyte in unknown samples.
1.9.6 Quality Control Samples
Analyze QC samples with known analyte concentrations to verif y the accuracy and
precision of the method. QC samples are used to monitor the method’s performance
over time.
1.9.7 Method Validation
Validate the analytical method to confirm its suitability for its intended purpose. This
includes assessing parameters such as accuracy, precision, specificity, and
robustness.
1.9.8 Use of Calibration Curve
When analyzing unknown samples, measure the instrument’s response and use the
calibration curve to determine the concentration or quantity of the analyte in the
sample.
1.9.9 Blank Correction
Subtract the response of the blank (no analyte) from the response of the sample to
account for any background signal or interference.
1.9.10 Record and Report Results
Document the calibration process, including standard preparation, instrument
settings, and results. Provide clear and accurate reports of the analyte concentrations
in the unknown samples.
Calibration
ceutical analysis. Regular monitoring and recalibration of instruments are important
to maintain the reliability of the method over time. Properly calibrated methods are
vital for meeting regulatory requirements and ensuring the quality and safety of
pharmaceutical products.
is essential to ensure the accuracy of quantitative analyses in pharma-
1.10 Statistical Analysis 43
1.10 Statistical Analysis
Statistical analysis tools are frequently used in pharmaceutical analysis to assess and
interpret data, conduct quality control, and make informed decisions about pharmaceutical products and processes. Various statistical methods and tools are employed
for different purposes. Here are some of the commonly used statistical analysis tools
in pharmaceutical analysis:
1.10.1 Descriptive Statistics
Descriptive statistics refers to a set of statistical tools used to summarize and describe
the main features of a collection of data. It helps provide a clear and concise
summary of the dataset through measures of central tendency, dispersion, and data
shape.
Key Components of Descriptive Statistics:
1. Measures of Central Tendency: These measures indicate the central or typical
values in the dataset.
• Mean: The average of all data points.
x
Mean =
" xi"
Where
is each individual data point, and “n” is the tota l number of data points.
• Median: The middle value when the data points are arranged in order.
• Mode: The most frequently occurring value in the dataset.
2. Measures of dispersion (variability): These describe how spread out the data
points are around the central value.
• Range: The difference between the largest and smallest values.
• Variance : The average of the squared differences from the mean.
i
n
2
x
- μð Þ
Variance =
i
n
Where μ is the mean of the data.
• Standard deviation: The square root of the variance, indicating the average
distance of each data point from the mean.
2
- μð Þ
x
Standard Deviation =
i
n
44 1 Comprehensive Insights into Pharmaceutical Analysis
• Interquartile range (IQR): The difference between the third quartile (Q3) and
the first quartile (Q1), showing the spread of the middle 50% of data.
3. Shape of data distribution:
• Skewness : Measures the asymmetry of the data distribution.
– Positive skew: When the tail on the right side is longer or fatter.
– Negative skew: When the tail
• Kurtosis:
– Leptokurtic: Distribution with heavy tails.
– Platykurtic: Distribution with light tails.
4. Other key metrics:
• Percentiles: Values below which
25th
• Quartiles : The data is divi ded into four equal parts.
– Q1: 25th percentile
– Q2: 50th percentile (median)
– Q3: 75th percentile
Descriptive statistics provide a foundational understanding of the dataset,
allowing you to quickly grasp the overall distribution, variation, and central tendency of the data. It is commonly used as the first step in data analysis before
applying inferential statistics or other more advanced techniques.
Describes
percentile
the “tailedness” or peakedness of the data distribution.
means 25% of the data is below this value).
left side is longer or fatter.
on the
a certain
percentage of data falls (e.g., the
1.10.2 Hypothesis Testing
Hypothesis testing involves statistical tests to determine whether there are significant
differences between groups or conditions. Common tests include t-tests, chi-squared
tests, and analysis of variance (ANOVA).
1.10.3 Regression Analysis
Regression analys is, including linear regression and multiple regression, is used to
model relationships between variables and predict outcomes. It can be applied in
pharmaceutical analysis for calibration curves, stability studies, and other predictive
modeling.
1.10.4 Design of Experiments
Design of experiments (DOE) is a structured approach to experimentation that helps
optimize processes and assess the effects of various factors on product quality. It is
often used in pharmaceutical process development.
1.10 Statistical Analysis 45
1.10.5 Control Charts
Control charts, such as Shewhart charts and X-bar charts, are used in quality control
to monitor and detect deviations from a stable process. They are crucial for assessing
the consistency of pharmaceutical manufacturing processes.
1.10.6 Capability Analysis
Capability analysis evaluates the capability of a process to meet specifications and
quality standards. It assesses whether a process is capable of producing products
within the desired range.
1.10.7 Multivariate Analysis
Techniques like principal component analysis and factor analysis are used to analyze
complex data sets with multiple variables. They can help identify patterns and
relationships in pharmaceutical data.
1.10.8 Nonparametric Statistics
Nonparametric tests, such as the Wilcoxon rank-sum test and the Mann– Whitney U
test, are used when data does not meet the assumptions of parametric tests. They are
valuable in cases with non-normal distributions.
1.10.9 Reliability Analysis
Reliability analysis assesses the reliability and failure rates of pharmaceutical
products and equipment. It is important in ensuring the quality and safety of
pharmaceutical products.
1.10.10 Cluster Analysis
Cluster analysis groups similar data points or samples together based on specific
characteristics. It can be used in pharmaceutical analysis to identify product or
sample similarities.
46 1 Comprehensive Insights into Pharmaceutical Analysis
1.10.11 Time Series Analysis
Time series analysis examines data collected over time to identify trends, patterns,
and seasonal variations. It can be applied to stability studies and process monitoring.
1.10.12 Survival Analysis
Survival analysis is used to analyze time-to-event data, such as the time to product
degradation. It is relevant in stability testing and shelf-life determination.
1.10.13 Monte Carlo Simulation
Monte Carlo simulation generates multiple random samples to assess the uncertainty
and variability of outcomes in pharmaceutical processes and quality control.
These statistical analysis tools help pharmaceutical analysts make informed
decisions, improve product quality, and ensure regulatory compliance. They are
integral to the pharmaceutical industry’s commitment to producing safe, effective,
and consistent ph armaceutical products.
1.10.14 Analysis of Variance
ANOVA is a statistical technique used in pharmaceutical analysis and various
scientific fields to assess the variation in data and determine whether significant
differences exist between groups or factors. In pharmaceutical analysis, ANOVA
plays a crucial role in quality control, method validation, and research, helping to
evaluate the sources of variability and ensure the reliability and validity of analytical
results. Here are the key aspects of ANOVA in pharmaceutical analysis:
1.10.14.1 Null Hypothesis
Null Hypothesis ( H0) assumes that all group means are equal.
H
: μ1 = μ2 = μ3 = ⋯ = μ
0
k
Where μ1 = μ2 = μ3 = ⋯ = μk are the means of the groups.
1.10.14.2 Alternative Hypothesis
Alternative Hypothesis (HA) assumes that at least one group mean is different.
: At least one mean is different from the others.
H
A
1.10.14.3 F-Statistic
The ANOVA test uses the F-statistic to compare the variance between groups to the
variance within groups. The formula for the F-statistic is:
1.10 Statistical Analysis 47
Variance Between Proups
F =
Variance Within Groups
If the F-statistic is significantly larger than 1, it indicates that there is more
nce between groups than within groups, suggesting that at least one group
varia
mean is different. A high F-value leads to rejecting the null hypothesis.
1.10.14.4 Types of ANOVA
1. One-way ANOVA: Compares the means of three or more independent (unrelated)
groups based on one independent variable.
• Example: Comparing the average blood pressure between three different age
groups.
2. Two-way ANOVA: Compares the means of groups classified by two independent
bles, also allowing for the investigation of the interaction between the
varia
variables.
• Example: Comparing the effectiveness of two drugs on patients with different
dosages
.
3. Repeated measures ANOVA: Used when the same subjects are measured mul tiple
times
under different conditions.
• Example: Testing the same group of patients before and after a treatment.
1.10.14.5 ANOVA Table
An ANOVA table is used to summarize the results of the analysis. It typically
includes:
• Source of variation: Identifies between-group and within-group (error) variations.
• Sum of squares: Sum of squares (SS) measures the total variation in the data.
– SS
– SS
: Variation due to differences between group means.
Between
: Variation due to differences within each group.
Within
• Degrees of freedom: Degrees of freedom (df) represents the number of indepen-
dent
values that can vary.
– df
– df
• Mean square: The sum of squares divi
= k - 1 (where k is the number of groups).
Between
= N - k (where N is the total number of observations).
Within
ded by their respective degrees of freedom
is known as mean square (MS).
– MS
– MS
Between
Within
= SS
= SS
Within
Between
/ df
/ df
Within
Between
• F-value : Calculated by dividing the mean square between by the mean square
within.
F MS
=
Between
=MS
Within
48 1 Comprehensive Insights into Pharmaceutical Analysis
1.10.14.6 Interpretation
• If the p value (probability value) associated with the F-statistic is less than the
significance level (typically 0.05), you reject the null hypothesis, concluding that
there is a statistically significant difference between the means of the groups.
• If the p value is greater than 0.05, the null hypothesis is not rejected, and you
conclude that any observed differences in means are likely due to random
variation.
1.10.14.7 Applications of ANOVA in Pharmaceutical Analysis
• Evaluating method performance: ANOVA is used to assess the precision and
accuracy of analytical methods. It can help identify sources of variability in a
method, such as different analysts, instruments, or laboratories, and determine
whether these variations are statistically significant.
• Quality control: In pharmaceutical quality control, ANOVA is applied to monitor
the consistency of analytical data, ensuring that products meet established
specifications. For example, ANOVA can be used to assess the variability in
drug product formulations, assay results, or impurity profiles.
• Comparing multiple samples or groups: ANOVA is valuable when comparing
data
from multip
le samples, groups, or batches. It helps determine whether there
are statistically significant differences between the groups and can pinpoint which
groups are responsible for the variations.
• Method validation: During method validation, ANOVA is employed to evaluate
the method’s accuracy, precision, and linearity. It assesses the method’s ability to
provide consistent results for a range of analyte concentrations and under various
conditions.
• Determination of sources of variability: ANOVA helps separate the variance in
data into components attributable to different sources, such as within-group
variance (due to random error), between-group variance (due to systematic
differences between groups), and interactions between factors. This separation
of variance components provides insights into the contributing factors to data
variability.
• Comparing means: ANOVA assesses whether the means of different groups are
significantly different from each other. It can be used to compare the mean
concentrations of analytes in different samples or batches.
• Method optimization: ANOVA can assist in optimizing analytical methods by
identifying influential factors or conditions that significantly impact the results. It
helps analysts make informed decisions to improve method performance.
• Data interpretation: NOV
in drawing conclusions from data by determin-
A aids
ing the statistical significance of differences. It helps researchers and analysts
make informed decisions based on data analysis.
• Regulatory compliance
: Regulatory agencies, such as the U.S. FDA and EMA,
require the use of statistical techniques like ANOVA in pharmaceutical analysis
to demonstrate method validity and ensure product quality.
1.11 Errors 49
ANOVA is a valuable statistical tool in pharmaceutical analysis for assessing the
sources of variability, comparing data between groups or samples, and ensuring the
accuracy, precision, and reliability of analytical methods. It is instrumental in quality
control, method validation, and research activities in the pharmaceutical industry,
contributing to the safety and efficacy of pharmaceutical products.
1.11 Errors
In pharmaceutical analysis, various types of errors can occur at different stages of the
analytical process. These errors can impact the accuracy and reliability of the results
and, consequently, the quality and safety of pharmaceutical products. Here are some
common types of errors that may appear during pharmaceutical analysis:
1.11.1 Systematic Errors
Systematic errors, also referred to as determinate errors, are identifiable and typically
can be either prevented or rectified. Pharmaceutical analysts are familiar with these
types of errors, which are characterized by their consistency. Systematic errors
encompass various subtypes, including:
• Instrumental errors: These result from inaccuracies in the
calibration, or equipment used in the analysis.
• Method errors: Systematic errors can arise from issues with the analytical method
itself, including nonlinearity, matrix effects, or interference from co-eluting
compounds.
• Standard solution errors: Errors in the preparation or handling of standard
solutions can introduce bias into the analysis.
• Matrix effects: Sample matrix effects can cause systematic errors when the matrix
interferes with the analyte’s measurement.
measuring inst
rument,
1.11.2 Precision Errors
• Random variability: Variability in measurements due to uncontrollable factors,
such as variations in environmental conditions, operator technique, or random
fluctuations in instruments.
• Reproducibility error
produce different results when analyzing the same sample.
s: Errors that occur when different analysts or laboratories